At the Retina Society meeting, Dr. Steven Yeh discussed the use of Xipere for treating noninfectious uveitis-associated macular edema. A study of 750 patients treated with Xipere showed positive results, with only 14% experiencing an elevation in intraocular pressure. Patients who received Xipere did not require rescue therapy, with 88% receiving only a single dose. This study demonstrated the durability of suprachoroidal injection of triamcinolone acetonide injectable suspension for uveitic macular edema. Dr. Yeh disclosed his consulting for Bausch + Lomb and involvement in the PEACHTREE trial.
Source link
Xipere demonstrates durability, safety in real-world setting
